HAE

Haemonetics Corporation

119.65

USD

-0.14

-0.12%

Oct 30, 15:59 UTC -4

Closed

After-Market

118.82

-0.83

-0.69%

Haemonetics Corporation (HAE) Earnings

HAE Earnings Reports

Positive Surprise Ratio

HAE beat 36 of 42 last estimates.

86%

Next Report

Next Week

Date of Next Report

Nov 04, 2026

Estimate for Q2 27 (Revenue/ EPS)

$348.45M

$1.30

Implied change from Q1 27 (Revenue/ EPS)

+2.67%

+15.04%

Implied change from Q2 26 (Revenue/ EPS)

+2.67%

+2.36%

Haemonetics Corporation earnings per share and revenue

On Aug 06, 2026, HAE reported earnings of 1.13 USD per share (EPS) for Q1 27, beating the estimate of 1.08 USD, resulting in a 4.82% surprise. Revenue reached 339.38 million, compared to an expected 331.17 million, with a 2.48% difference. The market reacted with a +1.70% price change (close before vs. close after earnings).

Looking ahead to Q2 27, 8 analysts forecast an EPS of 1.30 USD, with revenue projected to reach 348.45 million USD, implying an increase of 15.04% EPS, and increase of 2.67% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Abbott Laboratories

Report Date

Oct 21, 2026 For Q3 26

Estimate

$1.42

Actual

$1.42

Surprise

-0.68%

Stryker Corporation

Report Date

Oct 29, 2026 For Q3 26

Estimate

$3.58

Actual

$3.52

Surprise

-1.75%

Boston Scientific Corp.

Report Date

Oct 28, 2026 For Q3 26

Estimate

$0.72

Actual

$0.73

Surprise

+1.05%

ResMed Inc.

Report Date

Oct 29, 2026 For Q1 27

Estimate

$2.69

Actual

$2.91

Surprise

+7.79%

GE HealthCare Technologies Inc. Common Stock

Report Date

Oct 28, 2026 For Q3 26

Estimate

$1.22

Actual

$1.34

Surprise

+9.13%

Baxter International Inc.

Report Date

Oct 29, 2026 For Q3 26

Estimate

$0.52

Actual

$0.57

Surprise

+10.86%

Sundial Growers Inc. Common Shares

Report Date

Oct 27, 2026 For Q3 26

Estimate

-$0.02

Actual

-$0.04

Surprise

-101.26%

FAQ

What were Haemonetics Corporation's earnings and revenue for the latest quarter Q1 2027?

For Q1 2027, Haemonetics Corporation reported EPS of $1.13, beating estimates by 4.82%, and revenue of $339.38M, 2.48% above expectations.

How did the market react to Haemonetics Corporation's Q1 2027 earnings?

The stock price moved up 1.7%, changed from $83.60 before the earnings release to $85.02 the day after.

When is Haemonetics Corporation expected to report next?

The next earning report is scheduled for Nov 04, 2026.

What are the forecasts for Haemonetics Corporation's next earnings report?

Based on 8 analysts, Haemonetics Corporation is expected to report EPS of $1.30 and revenue of $348.45M for Q2 2027.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.